Walgreens Boots Alliance reported a $520 million “adverse Covid-19 impact” in its fourth quarter as the global drugstore chain begins a slow rebound during the pandemic.
Walgreens Boots Alliance reported a $520 million “adverse Covid-19 impact” in its fourth quarter as the global drugstore chain begins a slow rebound during the pandemic.